Medical Technology Giant BD (BDX.US) Reports Q3 Net Profit of $413 Million, Down 25.7% Year-Over-Year

Original Title: Medical Technology Giant BD (BDX.US) Reports Q3 Net Profit of $413 Million, Down 25.7% Year-on-Year Source: Zhitong Finance

Zhitong Finance APP learned that before the U.S. stock market opened on August 6, medical technology giant BD (Becton, Dickinson and Company, BDX.US) announced its financial report for the third quarter of fiscal year 2019. During this period, the company achieved revenue of $4.35 billion, a year-on-year increase of 1.7%, which fell short of market expectations; net profit attributable to shareholders was $413 million, a year-on-year decline of 25.7%. Diluted earnings per share amounted to $1.51, while adjusted earnings per share reached $3.08, slightly higher than market expectations.

The company reaffirmed that total revenue for fiscal year 2019 will grow by 8.0% to 9.0%, with adjusted diluted earnings per share ranging from $11.65 to $11.75, representing a growth rate of approximately 12%.

Notably, for the nine months ended June 30, 2019, the Company’s diluted earnings per share amounted to $3.49, compared to $1.27 in the same period of the prior year, representing a year-over-year increase of 174.8%.